Psychopharmacology Update 2021

This comprehensive program includes a current review of diagnostic and therapeutic issues and options and explores innovative treatment approaches in patients with various psychiatric conditions such as mood and anxiety disorders schizophrenia and ADHD. Premenstrual perinatal and perimenopausal depression are also covered. Learners can access webcasts and downloadable slides for future reference and use.

Share

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Independent Educational Activity

Intra Cellular Therapies

Neurocrine Biosciences

Sage Therapeutics, Inc.

Sunovion

Supernus Pharmaceuticals